Stocks-QURE-uniQure NV

QURE uniQure NV

25.69 -1.63 (-5.97%)
Invest

Overview

Prev Close25.69
Day's Range 25.38 - 28.16
52 Week Range 12.75 - 29.80
Average Volume (3m)676.03K
1-Year Return-7.83%
Beta1.0675
Market Cap1.2B
P/E Ratio2.64
Revenue61.43M
EPS-2.6846
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.716/06/202230/08/202209/11/202215.0017.5020.0022.5025.0027.50
Chart times in UTC
Industry Biotechnology
CEO Matt Kapusta, MBA, CPA
Employees 463

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: uniQure NV's revenues increased by 1,296.82% and amounted to 524.00M. Net income increased by 363.62% to 329.59M. Net assets increased by 144.27% to 595.78M and EPS increased from -2.81 to 7.04.
QURE's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
81.20%
Net Profit Margin
-663.83%
Operating Margin
-265.38%
Return On Investment
-27.63%
12/21
03/22
06/22
09/22
Total Revenue
57.69M
1.79M
497K
1.45M
Gross Profit
55.89M
-330K
-2.32M
-1.52M
Operating Income
7.67M
-51.88M
-57.66M
-59.52M
Net Income
8.21M
-46.68M
-39.06M
-47.86M